Makiko Iwasawa PharmD, PhD, BCPS
Position
Associate professor/lecturer
Division of Drug Information
Research and Education Center for Clinical Pharmacy
Kitasato University School of Pharmacy
Kitasato University Hospital
Education
- Ph.D, Kindai University Faculty of Pharmacy, 2020
- Pharm.D, University of Southern California School of Pharmacy, 2006
- B.S, Tokyo University of Pharmacy and Life Sciences, 1995
Selected Publications
- Makiko Iwasawa, Keiko Sagami, Satoshi Yokoyama, Kouichi Hosomi, Mitsutaka Takada. Influence of co-initiation of antiulcer drugs on persistence and adherence to low-dose aspirin: A retrospective cohort study using a Japanese claims database. Int J Clin Pharm Ther. 2020, 58(4): 214-222.
- Takeshi Horii, Makiko Iwasawa, Junichi Shimizu, Koichiro Atsuda. Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase-4 inhibitors in treatment-naive patients with type 2 diabetes in Japan. J Diabetes Investig. 2019, 11(1) 96-100.
- Takeshi Horii, Makiko Iwasawa, Yusuke Kabeya, Koichiro Atsuda. Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterized by drug class and patient characteristics: A Japanese database analysis. Sci Rep. 2019, 9(1):12992.
- Makiko Iwasawa, Keiko Sagami, Satoshi Yokoyama, Kouichi Hosomi, Mitsutaka Takada. Adherence to the guidelines for antiulcer drug prescription in patients receiving low-dose aspirin therapy in Japan. Int J Clin Pharm Ther. 2019, 57(4): 197-206.
- Takeshi Horii, Makiko Iwasawa, Junichi Shimizu, Koichiro Atsuda. Investigating the risk of bone fractures in elderly patients with type 2 diabetes mellitus: a retrospective study. BMC Endocr Disord. 2019, 19(1):81.
- Makiko Iwasawa, Kyoichi Wada, Mitsutaka Takada. Gastrointestinal risk factors and prescribing pattern of antiulcer agents in patients taking low-dose aspirin in Japan. Int J Pharm Pract. 2018; 26, 369-372.
Biograpy
About Makiko Iwasawa
Dr. Iwasawa is currently an associate professor/lecturer in the Division of Drug Information at Kitasato University School of Pharmacy.
Prior to her current position, she was a chief drug information pharmacist in the Pharmacy Department of the National Cerebral and Cardiovascular Center for two years.
After earning her Bachelor of Science degree from Tokyo University of Pharmacy and Life Sciences, she then went to study and earned her Pharm.D. degree from the University of Southern California in 2006 and completed her PGY 1 pharmacy practice residency at the University of California, Davis Health System.
As such, she has been a board-certified pharmacotherapy specialist in the US since 2007.
Most recently, she earned her Ph.D. in Pharmaceutical Sciences from Kindai University, and did her study on the use of antiulcer agents in patients receiving low-dose aspirin.
Her main teaching responsibilities include: lectures on hypertension in a pharmacotherapy course, drug information lectures and lab practices, and precepting fifth- and sixth-year pharmacy students for Special Research Work in a Pharmaceutical Sciences course. Her area of interests includes clinical pharmacy, medication safety, formulary management, and international pharmacy education. Dr. Iwasawa has published multiple original research articles in peer-reviewed journals, and published textbooks about pharmacotherapy and English for pharmacy students and pharmacists.
Dr. Iwasawa is an active member in the Japanese Society of Pharmaceutical Health Care and Science, Japanese Society of Hospital Pharmacist, Japanese Society of Drug Informatics, the Pharmaceutical Society of Japan, American College of Clinical Pharmacy, and American Society of Health-System Pharmacist. She currently serves as committee member for the Japanese Society of Drug Informatics, and is also a consultant for multiple companies.
Contact
ADDRESS : KITASATO UNIVERSITY HOSPITAL 1-15-1, Kitasato, Minami, Sagamihara Kanagawa 252-0375 JAPAN
TEL : +81-42-778-8089
FAX : +81-42-778-8060
Email : iwasawam@pharm.kitasato-u.ac.jp